Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 WuXi Biologics Completes Biologics Mfg. Facility in Ireland | Contract Pharma

What are you searching for?

Sign in
Breaking News

WuXi Biologics Completes Biologics Mfg. Facility in Ireland

Designed to adopt both large scale commercial manufacturing using disposable bioreactors and next-gen continuous bioprocessing manufacturing technology

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WuXi Biologics has completed the weather-tight seal of its biologics drug substance manufacturing facility on the Dundalk Campus in Ireland, marking the start of the company’s global biomanufacturing network.

As one of the world’s largest facilities using single-use bioreactors, this “Facility of the Future” began construction in February 2019 and completed the weather-tight seal of its main facility in December 2019. The facility is designed to adopt both large scale commercial manufacturing using disposable bioreactors and next-generation continuous bioprocessing manufacturing technology. It will have a total bioreactor capacity of 6,000 liters perfusion (MFG6) and 48,000 liters fed-batch (MFG7) after full completion.

“We are proud of achieving this great milestone 10 months after initiating the facility construction of our first global site in Europe, which is another testament of ‘WuXi Bio Speed’ implemented outside of China for the first time. Construction of our US facility will also begin soon as well.” said Dr. Chris Chen, CEO of WuXi Biologics. “As a global company, we are building capabilities and capacities in the U.S., Europe and China to serve our clients and to benefit patients worldwide.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics